Breast cancer risk factors in Queensland women attending population-based mammography screening

被引:10
作者
Protani, Melinda
Page, Andrew [1 ]
Taylor, Richard [2 ]
Glazebrook, Roz [3 ]
Lahmann, Petra H. [4 ]
Branch, Elise
Muller, Jennifer [3 ]
机构
[1] Univ Queensland, Sch Populat Hlth, Discipline Epidemiol & Biostat, Herston, Qld 4006, Australia
[2] Univ New S Wales, SPHCM, Randwick, NSW, Australia
[3] BreastScreen Queensland State Coordinat Unit, Herston, Qld 4006, Australia
[4] Queensland Inst Med Res Canc & Populat Studies, Brisbane, Qld 4006, Australia
关键词
Breast cancer; Risk factors; Family history; Hormone replacement therapy; Complementary medicines; Reproductive factors; HORMONE-REPLACEMENT THERAPY; RANDOMIZED CONTROLLED-TRIAL; ESTROGEN PLUS PROGESTIN; HEALTHY POSTMENOPAUSAL WOMEN; ALTERNATIVE MEDICATIONS; SELF-REPORT; AUSTRALIA; COMPLEMENTARY; HYSTERECTOMY; METAANALYSIS;
D O I
10.1016/j.maturitas.2011.12.008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To investigate the prevalence of established modifiable and non-modifiable risk factors associated with breast cancer in Queensland (Australia) women. Study design: Cross-sectional prevalence study of 9792 women (58% of women sent the questionnaire) attending BreastScreen Queensland Screening and Assessment Services between November 2008 and February 2009. Prevalence and 95% confidence intervals were calculated for each risk factor, stratified by age-group (45-49 years, 50-59 years, 60-69 years, >= 70 years). Main outcome measures: First-degree family history (FH) of breast cancer (mother, sister, daughter), reproductive history, behavioural factors, co-morbidities, use of hormone replacement therapy (HRT) and alternatives, and socio-demographic factors. Results: The prevalence of first-degree FH of breast cancer was 16% and a previous diagnosis of breast cancer was 3.5%; both are considered major risk factors for breast cancer. The prevalence of modifiable breast cancer risk factors of moderate risk were: current HRT use (12%), HRT use within the past 5 years (7%), overweight [body mass index 25-29] (33%) or obesity [BMI > 30] (27%), alcohol consumption [>= 11 drinks/week] (10%), sedentary behaviour (70%), and low fruit (34%) and vegetable consumption (69%). These risk factors tended to be higher in younger women (45-49 years) compared to older women (>50 years). Conclusion: Prevalence of risk factors in Queensland women were largely consistent with other Australian and international studies. Hormone therapy use is lower than previously reported estimates in Australia and internationally. The comparatively high prevalence of modifiable lifestyle factors which have been shown to be moderately associated with breast cancer are potential targets for reducing the public health burden of breast cancer. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 41 条
  • [1] Abbott S, 2002, BJOG-INT J OBSTET GY, V109, P1319
  • [2] Prior hormone therapy and breast cancer risk in the Women's Health initiative randomized trial of estrogen plus progestin
    Anderson, Garnet L.
    Chlebowski, Rowan T.
    Rossouw, Jacques E.
    Rodabough, Rebecca J.
    McTiernan, Anne
    Margolis, Karen L.
    Aggerwal, Anita
    Curb, J. David
    Hendrix, Susan L.
    Hubbell, F. Allan
    Khandekar, Jamardan
    Lane, Dorothy S.
    Lasser, Norman
    Lopez, Ana Maria
    Potter, JoNell
    Ritenbaugh, Cheryl
    [J]. MATURITAS, 2006, 55 (02) : 103 - 115
  • [3] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
    Anderson, GL
    Limacher, M
    Assaf, AR
    Bassford, T
    Beresford, SAA
    Black, H
    Bonds, D
    Brunner, R
    Brzyski, R
    Caan, B
    Chlebowski, R
    Curb, D
    Gass, M
    Hays, J
    Heiss, G
    Hendrix, S
    Howard, BV
    Hsia, J
    Hubbell, A
    Jackson, R
    Johnson, KC
    Judd, H
    Kotchen, JM
    Kuller, L
    LaCroix, AZ
    Lane, D
    Langer, RD
    Lasser, N
    Lewis, CE
    Manson, J
    Margolis, K
    Ockene, J
    O'Sullivan, MJ
    Phillips, L
    Prentice, RL
    Ritenbaugh, C
    Robbins, J
    Rossouw, JE
    Sarto, G
    Stefanick, ML
    Van Horn, L
    Wactawski-Wende, J
    Wallace, R
    Wassertheil-Smoller, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14): : 1701 - 1712
  • [4] [Anonymous], 1999, ACC REM IND AUSTR AR
  • [5] [Anonymous], 2003, ACT AUSTR SURV GUID
  • [6] [Anonymous], 2001, Australian alcohol guidelines: health risks and benefits
  • [7] Australian Bureau of Statistics, 2009, 43640 AUSTR BUR STAT
  • [8] Australian Bureau of Statistics, 2010, CDATA ONL
  • [9] Australian Institute of Health and Welfare & National Breast and Ovarian Cancer Centre, 2009, BREAST CANC AUSTR OV
  • [10] Banks E, 2001, J Epidemiol Biostat, V6, P357